MWN-109

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NameMWN-109
Drug Alias NameMWN-109
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightBody WeightObesity +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Minwei Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Minwei Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A